NLRP3 and Alzheimer disease: NLRP3 is upregulated in an animal model of AD causing IFN1β production by microglia and inhibition of NLRP3 reduced the deposition of amyloid-β (140). AD patients exhibited NLRP3 inflammasome assembly and activation with high amounts of IL-1β and IL-18 (140).